Medis El (Israel) links up with Institut Pasteur
This article was originally published in Clinica
Executive Summary
Medis El (Israel) has signed an agreement with the Institut Pasteur in Paris, France, to use the company's CellScan System for AIDS research and therapy. The research programme will investigate lymphocyte activity and behaviour. CellScan uses blood samples to detect HIV, infectious and autoimmune diseases and breast, colon and lung cancer.